Startups

Former BharatPe Co-founder Ashneer Grover Ventures into Fintech Again with ZeroPe App for Medical Loans


Former co-founder and managing director of BharatPe, Ashneer Grover, is gearing up for a re-entry into the fintech sphere with the launch of ZeroPe, an app dedicated to providing medical loans. ZeroPe, currently in its testing phase, has been developed by Grover’s venture, Third Unicorn, as listed on the Google Playstore.

Third Unicorn, initiated by Grover post his departure from BharatPe, previously unveiled CrickPe, a fantasy gaming platform, in 2023. Now, ZeroPe aims to offer instant pre-approved medical loans of up to Rs 5 lakhs, in collaboration with Delhi-based Non-Banking Financial Company (NBFC) Mukut Finvest. These loans will exclusively be accessible at partnered hospitals, as stated on the ZeroPe app’s website.

Grover’s latest endeavor adds to the expanding landscape of businesses focusing on providing instant financing solutions for medical expenses and elective treatments. ZeroPe joins the likes of SaveIn, Qube Health, Arogya Finance, Neodocs, Fibe, Kenko, and Mykare Health in catering to the growing demand for medical financing options.

Established in January 2023 by Ashneer Grover, Madhuri Jain Grover, and Chandigarh-based entrepreneur Aseem Ghavri, Third Unicorn initially ventured into the realm of fantasy gaming with CrickPe. The company secured $3.5 million in a seed round, with ZNL Growth Fund leading the investment, along with Vevek Ventures Investments and Rishaayu LLP.

With an eye on the burgeoning digital healthcare market in India, characterized by a projected revenue of $37 billion by 2030, Grover’s ZeroPe aims to tap into the healthcare financing segment, estimated to reach $5 billion. This aligns with the broader trend of digital-first startups striving to provide data-driven medical loans catering to various healthcare needs, encompassing hospitalization, home care, and chronic care management.

Follow Startup Story

Related Posts

© Startup Story Private Limited. All Rights Reserved.